159 related articles for article (PubMed ID: 8877007)
1. Circulating levels of the macrophage colony stimulating factor CSF-1 in primary and metastatic breast cancer patients. A pilot study.
Scholl SM; Lidereau R; de la Rochefordière A; Le-Nir CC; Mosseri V; Noguès C; Pouillart P; Stanley FR
Breast Cancer Res Treat; 1996; 39(3):275-83. PubMed ID: 8877007
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1.
Chambers SK; Kacinski BM; Ivins CM; Carcangiu ML
Clin Cancer Res; 1997 Jun; 3(6):999-1007. PubMed ID: 9815777
[TBL] [Abstract][Full Text] [Related]
3. Circulating macrophage colony stimulating factor as a marker of tumour progression.
McDermott RS; Deneux L; Mosseri V; Védrenne J; Clough K; Fourquet A; Rodriguez J; Cosset JM; Sastre X; Beuzeboc P; Pouillart P; Scholl SM
Eur Cytokine Netw; 2002; 13(1):121-7. PubMed ID: 11956031
[TBL] [Abstract][Full Text] [Related]
4. Elevated CSF1 serum concentration predicts poor overall survival in women with early breast cancer.
Aharinejad S; Salama M; Paulus P; Zins K; Berger A; Singer CF
Endocr Relat Cancer; 2013 Dec; 20(6):777-83. PubMed ID: 24016870
[TBL] [Abstract][Full Text] [Related]
5. The role of colony-stimulating factor 1 and its receptor in the etiopathogenesis of endometrial adenocarcinoma.
Smith HO; Anderson PS; Kuo DY; Goldberg GL; DeVictoria CL; Boocock CA; Jones JG; Runowicz CD; Stanley ER; Pollard JW
Clin Cancer Res; 1995 Mar; 1(3):313-25. PubMed ID: 9815987
[TBL] [Abstract][Full Text] [Related]
6. Comparative evaluation of plasma levels and diagnostic values of macrophage-colony stimulating factor in patients with breast cancer and benign tumors.
Ławicki S; Czygier M; Bedkowska E; Wojtukiewicz M; Szmitkowski M
Pol Arch Med Wewn; 2008 Sep; 118(9):464-9. PubMed ID: 18846980
[TBL] [Abstract][Full Text] [Related]
7. Serum macrophage colony-stimulating factor (M-CSF) levels in patients with epithelial ovarian cancer.
Gadducci A; Ferdeghini M; Castellani C; Annicchiarico C; Prontera C; Facchini V; Bianchi R; Genazzani AR
Gynecol Oncol; 1998 Jul; 70(1):111-4. PubMed ID: 9698485
[TBL] [Abstract][Full Text] [Related]
8. [The plasma levels of granulocyte-colony stimulating factor (G-CSF) and macrophage-colony stimulating factor (M-CSF) in breast cancer patients].
Lawicki S; Czygier M; Omyła J; Szmitkowski M
Pol Arch Med Wewn; 2006 Aug; 116(2):749-55. PubMed ID: 17424919
[TBL] [Abstract][Full Text] [Related]
9. Phase I trial of recombinant human macrophage colony-stimulating factor administered by continuous intravenous infusion in patients with metastatic cancer.
Cole DJ; Sanda MG; Yang JC; Schwartzentruber DJ; Weber J; Ettinghausen SE; Pockaj BA; Kim HI; Levin RD; Pogrebniak HW
J Natl Cancer Inst; 1994 Jan; 86(1):39-45. PubMed ID: 8271281
[TBL] [Abstract][Full Text] [Related]
10. Serum macrophage-colony stimulating factor levels in colorectal cancer patients correlate with lymph node metastasis and poor prognosis.
Mroczko B; Groblewska M; Wereszczyńska-Siemiatkowska U; Okulczyk B; Kedra B; Łaszewicz W; Dabrowski A; Szmitkowski M
Clin Chim Acta; 2007 May; 380(1-2):208-12. PubMed ID: 17368603
[TBL] [Abstract][Full Text] [Related]
11. [The plasma levels and diagnostic utility of granulocyte-colony stimulating factor (G-CSF) and granulocyte-macrophage - colony stimulating factor (GM-CSF) in patients with I and II stage of breast cancer].
Ławicki S; Czygier M; Wojtukiewicz M; Szmitkowski M
Przegl Lek; 2009; 66(7):365-9. PubMed ID: 20043577
[TBL] [Abstract][Full Text] [Related]
12. [Plasma level of macrophage-colony stimulating factor (M-CSF) in the course of breast cancer treatment].
Lawicki S; Omyła J; Mroczko B; Szmitkowski M; Czygier M
Pol Arch Med Wewn; 2004 Oct; 112(4):1181-7. PubMed ID: 15773430
[TBL] [Abstract][Full Text] [Related]
13. The pretreatment plasma level and diagnostic utility of M-CSF in benign breast tumor and breast cancer patients.
Ławicki S; Szmitkowski M; Wojtukiewicz M
Clin Chim Acta; 2006 Sep; 371(1-2):112-6. PubMed ID: 16631152
[TBL] [Abstract][Full Text] [Related]
14. The activated macrophage colony-stimulating factor (CSF-1) receptor as a predictor of poor outcome in advanced epithelial ovarian carcinoma.
Toy EP; Chambers JT; Kacinski BM; Flick MB; Chambers SK
Gynecol Oncol; 2001 Feb; 80(2):194-200. PubMed ID: 11161859
[TBL] [Abstract][Full Text] [Related]
15. Circulating levels of colony-stimulating factor 1 as a prognostic indicator in 82 patients with epithelial ovarian cancer.
Scholl SM; Bascou CH; Mosseri V; Olivares R; Magdelenat H; Dorval T; Palangié T; Validire P; Pouillart P; Stanley ER
Br J Cancer; 1994 Feb; 69(2):342-6. PubMed ID: 8297732
[TBL] [Abstract][Full Text] [Related]
16. Anti-colony-stimulating factor-1 antibody staining in primary breast adenocarcinomas correlates with marked inflammatory cell infiltrates and prognosis.
Scholl SM; Pallud C; Beuvon F; Hacene K; Stanley ER; Rohrschneider L; Tang R; Pouillart P; Lidereau R
J Natl Cancer Inst; 1994 Jan; 86(2):120-6. PubMed ID: 8271294
[TBL] [Abstract][Full Text] [Related]
17. The efficacy of recombinant human granulocyte colony-stimulating factor and recombinant human granulocyte macrophage colony-stimulating factor in permitting the administration of higher doses of cyclophosphamide in a doxorubicin-cyclophosphamide combination. An NSABP pilot study in patients with metastatic or high-risk primary breast cancer. National Surgical Adjuvant Breast and Bowel Project.
Mamounas EP; Anderson S; Wickerham DL; Clark R; Stoller R; Hamm JT; Stewart JA; Bear HD; Glass AG; Bornstein R
Am J Clin Oncol; 1994 Oct; 17(5):374-81; discussion 382. PubMed ID: 7522393
[TBL] [Abstract][Full Text] [Related]
18. Hematopoietic cytokines as tumor markers in breast malignancies. A multivariate analysis with ROC curve in breast cancer patients.
Ławicki S; Będkowska GE; Wojtukiewicz M; Szmitkowski M
Adv Med Sci; 2013; 58(2):207-15. PubMed ID: 23846151
[TBL] [Abstract][Full Text] [Related]
19. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
20. Stem cell factor and macrophage-colony stimulating factor in patients with pancreatic cancer.
Mroczko B; Szmitkowski M; Wereszczynska-Siemiatkowska U; Jurkowska G
Clin Chem Lab Med; 2004 Mar; 42(3):256-60. PubMed ID: 15080556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
